World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Ward JA, Yerke J, Lumpkin M, Kapoor A, Lindenmeyer CC, Bass S. Evaluation of a protocol for rifaximin discontinuation in critically ill patients with liver disease receiving broad-spectrum antibiotic therapy. World J Hepatol 2023; 15(11): 1226-1236 [PMID: 38075005 DOI: 10.4254/wjh.v15.i11.1226]
URL:	https://www.wjgnet.com/1948-5182/full/v15/i11/1226.htm

(123) (138) (0) (0) (0) (11) (4659) (6)

Number	Citing Articles
1	Wen Wang, Ying Wen. The role of systemic inflammation in hepatic encephalopathy: advances in inflammatory mechanisms, prevention and treatment research. Annals of Medicine 2026; 58(1) doi: 10.1080/07853890.2026.2650232
2	Alessandro Mari, Lorenzo Ridola. Rifaximin discontinuation during broad-spectrum antibiotic treatment in critically ill patients with hepatic encephalopathy. World Journal of Hepatology 2024; 16(11): 1356-1360 doi: 10.4254/wjh.v16.i11.1356 Abstract(567) \| Core Tip(584) \| Full Article(HTML)(1703) \| Full Article (PDF)-369K(251) \| Full Article with Cover (PDF)-2476K(146) \| Full Article (XML)-59K(132) \| Audio-16465K(16) \| Peer-Review Report-394K(98) \| Answering Reviewers-69K(122) \| Times Cited (0) \| Total Visits (2610) \| Open
3	Jasmohan S. Bajaj, Sofia S. Jakab, Arun B. Jesudian, Robert S. Rahimi, Andres Duarte-Rojo, Po-Hung Chen, Robert J. Wong, Elliot B. Tapper, Puneeta Tandon. ACG Clinical Guideline: Hepatic Encephalopathy. American Journal of Gastroenterology 2026; 121(3) doi: 10.14309/ajg.0000000000003899
4	Piero Amodio, Chien-Hao Huang. Can rifaximin for hepatic encephalopathy be discontinued during broad-spectrum antibiotic treatment?. World Journal of Hepatology 2024; 16(2): 115-119 doi: 10.4254/wjh.v16.i2.115 Abstract(795) \| Core Tip(663) \| Full Article(HTML)(3026) \| Full Article (PDF)-363K(205) \| Full Article with Cover (PDF)-875K(215) \| Full Article (Word)-129K(25) \| Full Article (XML)-64K(143) \| Audio-162K(31) \| Peer-Review Report-172K(127) \| Answering Reviewers-129K(129) \| Times Cited (3) \| Total Visits (3614) \| Open
5	Zhaohui Bai, Congcong Li, Yongjie Lai, Xiaojuan Hu, Luwen Shi, Xiaodong Guan, Yang Xu. Role of Rifaximin in the Prognosis of Critically Ill Patients with Liver Cirrhosis. Antibiotics 2025; 14(3) doi: 10.3390/antibiotics14030287
6	Xigang Ma, Yongsen Zhao. Gut‑brain axis in anesthesia and critical illness: Molecular crosstalk and its impact on delirium and outcome (Review). International Journal of Molecular Medicine 2026; 58(1) doi: 10.3892/ijmm.2026.5859

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.